Ipsat Therapies Ltd

Ipsat Therapies Ltd is a Finnish biotechnology company developing its proprietary IPSAT™ (“Intestinal Protection System in Antibiotic Treatment”) family of products for the prevention of hospital infections and antibiotic resistance.

Currently open positions:
Director, Finance & Admistration
Regulatory Consultant
Business Development Manager

Preventing Antibiotic Resistance and prolonging the life-span of Antibiotics

NEWS

25.10.2007
Ipsat Therapies Announces Positive Top-line Data from Phase IIb Study of Ipsat P1A.

17.9.2007
Ipsat is presenting "a Novel Strategy to Prevent Colonization by Clostridium difficile" at ICAAC 17-20th September 2007.

5.7.2007
Ipsat Therapies has completed patient recruiment in Phase IIb clinical trial.

31.3.2007
The effect of Ipsat P1A, a novel drug for prevention of antibiotic-induced intestinal pathogenic colonization, on the gut antibiotic levels after intravenous administration of beta lactam antibiotic/beta lactamase inhibitors in the dog.